The U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, endoscopic retrograde cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. The largest segment in the total GI endoscopic device market was the GI flexible endoscope segment. This segment represented approximately 24.5% of the total market in 2016. The relatively large size of this segment is due to a combination of relatively high average selling price (ASP) coupled with relatively short life-span of five years, resulting in constant renewal of the equipment. One of the main drivers in this market is the growth in the procedure numbers, such as colonoscopy and therapeutic ERCP. Colonoscopy has become a gold-standard in the colorectal cancer screening program, with more than 18 million procedures performed annually. A lot of devices discussed in this report are used in conjunction with the each other, thus having a multiplication effect on the size of the market with each extra proceThe full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes. dure performed.
The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.
'
TABLE OF CONTENTS I
LIST OF FIGURES VII
LIST OF CHARTS XIV
EXECUTIVE SUMMARY 1
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
PROCEDURE NUMBERS 9
PROCEDURE CODES INVESTIGATED 10
MARKETS INCLUDED 11
1.1 KEY REPORT UPDATES 15
VERSION HISTORY 15
RESEARCH METHODOLOGY 16
1.1 RESEARCH SCOPE 16
1.2 IDATA’S 9-STEP METHODOLOGY 16
Step 1: Project Initiation & Team Selection 16
Step 2: Prepare Data Systems and Perform Secondary Research 18
Step 3: Preparation for Interviews & Questionnaire Design 19
Step 4: Performing Primary Research 20
Step 5: Research Analysis: Establishing Baseline Estimates 22
Step 6: Market Forecast and Analysis 23
Step 7: Identify Strategic Opportunities 25
Step 8: Final Review and Market Release 26
Step 9: Customer Feedback and Market Monitoring 27
DISEASE OVERVIEW 28
2.1 BASIC ANATOMY 28
2.2 GASTROINTESTINAL DISEASE: TREATMENT AND DIAGNOSTICS 29
2.2.1 Gastro-Esophageal Reflux Disease (GERD) 32
2.2.2 Barrett's Esophagus 33
2.2.3 Digestive Cancer 33
2.2.4 Gastrointestinal bleeding 35
2.2.5 Bile Duct Disorders 36
2.2.6 Crohn’s disease 37
2.2.7 Ulcer 37
2.2.8 Ogilvie Syndrome or Intestinal Pseudo-Obstruction 38
2.3 PATIENT DEMOGRAPHICS 40
2.3.11 Patient Demographics 40
2.3.11.1 All Digestive Diseases 40
2.3.11.2 Abdominal Wall Hernia 42
2.3.11.3 Chronic Constipation 42
2.3.11.4 Diverticular Disease 42
2.3.11.5 Prescriptions 42
2.3.11.6 Gastroesophageal Reflux Disease 43
2.3.11.7 Gastrointestinal Infections 43
2.3.11.8 Hemorrhoids 43
2.3.11.9 Inflammatory Bowel Disease 44
2.3.11.10 Liver Disease 44
2.3.11.11 Pancreatitis 45
2.3.11.12 Peptic Ulcer Diseases 45
2.3.12 Digestive Cancer 46
PRODUCT ASSESSMENT 49
3.1 PRODUCT PORTFOLIOS 49
3.1.1 Gastrointestinal Endoscopes 49
3.1.1.1 Introduction 49
3.1.1.1.1 Product Matrix for GI Endoscope Market 52
3.1.2 Capsule Endoscopy 55
3.1.2.1 Introduction 55
3.1.2.1.1 Product Matrix for Capsule Endoscope Market 57
3.1.3 Virtual Colonoscopy 58
3.1.3.1 Introduction 58
3.1.3.1.1 Product Matrix for Virtual Colonoscopy Market 59
3.1.4 Stenting and Dilation devices 61
3.1.4.1 Introduction 61
3.1.4.1.1 Product Matrix for Stenting and Dilation Device Market 63
3.1.5 Endoscopic Retrograde Cholangiopancreatography (ERCP) devices 64
3.1.5.1 Introduction 64
3.1.5.1.1 Product Matrix for ERCP Device Market 65
3.1.6 Biopsy Forceps, Polypectomy Snares, Fine Aspiration Needles 70
3.1.6.1 Introduction 70
3.1.6.1.1 Product Matrix for Biopsy Forceps, Polypectomy Snares and FNA 71
3.1.7 Foreign Body Retrieval and Specimen Removal devices 73
3.1.7.1 Introduction 73
3.1.7.1.1 Product matrix for Specimen Retrieval and Foreign Body Removal Devices 74
3.1.8 Hemostasis Devices 76
3.1.8.1 Introduction 76
3.1.8.1.1 Product Matrix for Hemostasis Devices 78
3.1.9 Enteral Feeding Devices 81
3.1.9.1 Introduction 81
3.1.9.1.1 Product Matrix for Enteral Feeding Devices 82
3.1.10 Anti-Reflux Devices for Treatment of GERD 87
3.1.10.1 Introduction 87
3.1.10.1.1 Product Matrix for Anti-Reflux Device Market 89
3.1.11 Barrett’s Esophagus Ablation devices 90
3.1.11.1 Introduction 90
3.1.11.1.1 Product Matrix for Barret’s Esophagus Ablation Device Market 91
3.2 REGULATORY ISSUES AND RECALLS 92
3.2.1 Gastrointestinal endoscopes 92
3.2.2 Refurbishment endoscopes 96
3.2.3 Stenting and Dilation device 97
3.2.4 Biopsy Forceps, Polypectomy Snares, Fine Aspiration Needles 98
3.2.5 Foreign Body Retrieval and Specimen Removal devices 99
3.2.6 Endoscopic Retrograde Cholangiopancreatography (ERCP) devices 100
3.2.7 Hemostasis devices 101
3.2.8 Enteral Feeding Devices 102
3.2.9 Anti-Reflux devices for treatment of GERD – and capsule 106
3.2.10 Barrett’s Esophagus Ablation devices 107
3.3 CLINICAL TRIALS 108
3.3.1 Gastrointestinal Endoscopes 109
3.3.2 Capsule Endoscopy 117
3.3.3 Virtual Colonoscopy 121
3.3.4 Stenting and Dilation Device 123
3.3.5 Endoscopic Retrograde Cholangiopancreatography (ERCP) devices 128
3.3.6 Biopsy Forceps, Polypectomy Snares and Fine Aspirational Needle 136
3.3.7 Foreign Body and Specimen Removal devices 142
3.3.8 Hemostasis devices 143
3.3.9 Enteral Feeding Devices 144
3.3.10 Anti-Reflux (GERD) devices 145
3.3.11 Barrett’s Esophagus Ablation devices 147
3.4 PRODUCT PIPELINES 150
3.4.1 Boston Scientific 150
3.4.1.1 AXIOS™ Stent and Electrocautery Enhanced Delivery System 150
3.4.1.2 Acquire™ Endoscopic Ultrasound Fine Needle Biopsy (FNB) Device 150
3.4.1.3 Safe Enteral Feeding Product 150
3.4.1.4 Rotatable Snare 151
3.4.2 Cook Inc. 151
3.4.2.1 Lehman Manometry Catheter 151
3.4.3 Olympus 151
3.4.3.1 Olympus EZ Shot 3 Plus - a single-use aspiration needle 151
3.4.3.2 Olympus ESG-200 Electrosurgical Generator 151
3.4.3.3 Retooled GI Benchmarking Service 151
3.4.3.4 Big Screen Surgery In 4K: VISERA 4K UHD System 152
3.4.3.5 TJF-Q180V Duodenoscope 152
3.4.3.6 From AR 2015 – new strategy plan for General Surgery Unit 152
3.4.4 Medtronic / Covidien 153
3.4.4.1 Safe Enteral Feeding Product line 2016 153
3.4.4.2 Barrx 360 Express RFA balloon catheter for Barrett's Esophagus 153
3.4.5 Avantis Medical Systems 154
3.4.5.1 Third Eye Panoramic Colonoscopy Device 154
3.4.6 Pentax Medical/ HOYA 154
3.4.6.1 H OPTIVISTA-EPK-i7010 Video Processor for endoscopy 154
3.4.7 Fujifilm 154
3.4.7.1 Sonart SU-1 Endoscopic Ultrasonic Processors 154
3.4.7.2 Double Balloon Endoscope (EN-580T) 154
3.4.8 US Endoscopy 154
3.4.8.1 Moray® micro forceps 154
3.4.9 CONMED Corporation 155
3.4.9.1 ABC D-Flex Probes 155
3.4.10 EndoChoice 155
3.4.10.1 FDA clearance for Orca™ Sterile, Single-Use Air/Water and Suction Valves 155
3.4.10.2 Third generation Fuse® Full Spectrum Endoscopy® System 155
3.4.10.3 RescueNet™ retrieval device 155
3.4.10.4 Lumos™ Adaptive Matrix Imaging System 155
3.4.11 Endogastric Solution 156
3.4.11.1 Next-generation version of EsophyX® Device - EsophyX® Z 156
3.4.12 Mederi Therapeutics 156
3.4.12.1 Stretta RFT3 Technology 156
3.4.13 C2 Therapeutics 157
3.4.13.1 Coldplay III Trial Validating the C2 CryoBalloon™ Focal Ablation System for treating Barret’s Esophagus 157
3.4.14 Medigus 157
3.4.14.1 Next generation MUSE™ System for the long-term treatment of GERD 157
3.4.15 Merit Medical Systems, Inc. 157
3.4.15.1 Corvocet Biopsy System 157
3.4.16 Medivators, Inc. 157
3.4.16.1 AmplifEYE™ endoscopic overtube 157
3.4.17 Fujifilm Medical Systems USA, Inc. 158
3.4.17.1 Fujifilm Diathermic Slitter (flushknife) and Fujifilm Diathermic Slitter (clutchcutter) 158
3.4.17.2 New additions for Double Balloon Endoscopy (DBE) platform and the Advanced Endoscopic Platform including FlushKnife and ClutchCutter 158
3.4.18 Cook Medical 158
3.4.18.1 New study “A Multicenter Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device (ASPRO)” 158
3.4.19 Vital Images, Inc. 159
3.4.19.1 Vitrea CT Colon Analysis 159
ABBREVIATIONS 160
Chart 1 1: Gastrointestinal Endoscopic Device Market by Segment, U.S., 2013 – 2023 2
Chart 1 2: Gastrointestinal Endoscopic Device Market Overview, U.S., 2016 & 2023 2
Chart 2 1: Male Incidence, Digestive Cancer, U.S., 2016 47
Chart 2 2: Male Deaths, Digestive Cancer, U.S., 2016 47
Chart 2 3: Female Incidence, Digestive Cancer, U.S., 2016 48
Chart 2 4: Female Deaths, Digestive Cancer, U.S., 2016 48
Figure 1 1: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (1 of 2) 4
Figure 1 2: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (2 of 2) 4
Figure 1 3: Companies Researched in this Report, U.S., 2016 5
Figure 1 4: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (1 of 2) 6
Figure 1 5: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (2 of 2) 7
Figure 1 6: Recent Events in the Gastrointestinal Endoscopic Device Market, U.S., 2012 – 2016 8
Figure 1 7: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 9
Figure 1 8: Procedure Codes Investigated, U.S., 2016 10
Figure 1 9: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (1 of 4) 11
Figure 1 10: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (2 of 4) 12
Figure 1 11: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (3 of 4) 13
Figure 1 12: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (4 of 4) 14
Figure 1 13: Key Report Updates 15
Figure 1 14: Version History 15
Figure 2 1: Leading Physician Diagnoses for GI Disorders, U.S., 2009 31
Figure 2 2: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (1 of 2) 40
Figure 2 3: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (2 of 2) 41
Figure 2 4: Digestive Cancer Statistics by Type and Gender, U.S., 2016 46
Figure 3 1: Core Companies, GI Endoscope Market, U.S., 2016 (1 of 3) 52
Figure 3 2: Core Companies, GI Endoscope Market, U.S., 2016 (2 of 3) 53
Figure 3 3: Core Companies, GI Endoscope Market, U.S., 2016 (3 of 3) 54
Figure 3 4: Core Companies, Capsule Endoscope Market, U.S., 2016 57
Figure 3 5: Core Companies, Virtual Endoscope Market, U.S., 2016 (1 of 2) 59
Figure 3 6: Core Companies, Virtual Endoscope Market, U.S., 2016 (2 of 2) 60
Figure 3 7: Core Companies, Stenting and Dilation Market, U.S., 2016 63
Figure 3 8: Core Companies, Stenting and Dilation Market, U.S., 2016 (1 of 5) 65
Figure 3 9: Core Companies, Stenting and Dilation Market, U.S., 2016 (2 of 5) 66
Figure 3 10: Core Companies, Stenting and Dilation Market, U.S., 2016 (3 of 5) 67
Figure 3 11: Core Companies, Stenting and Dilation Market, U.S., 2016 (4 of 5) 68
Figure 3 12: Core Companies, Stenting and Dilation Market, U.S., 2016 (5 of 5) 69
Figure 3 13: Core Companies, Biopsy Forceps, Polypectomy Snares and FNA Market, U.S., 2016 (1 of 2) 71
Figure 3 14: Core Companies, Biopsy Forceps, Polypectomy Snares and FNA Market, U.S., 2016 (2 of 2) 72
Figure 3 15: Core Companies, Retrieval and Foreign Body Removal Device Market, U.S., 2016 (1 of 2) 74
Figure 3 16: Core Companies, Retrieval and Foreign Body Removal Device Market, U.S., 2016 (2 of 2) 75
Figure 3 17: Core Companies, Hemostasis Device Market, U.S., 2016 (2 of 3) 78
Figure 3 18: Core Companies, Hemostasis Device Market, U.S., 2016 (2 of 3) 79
Figure 3 19: Core Companies, Hemostasis Device Market, U.S., 2016 (3 of 3) 80
Figure 3 20: Core Companies, Enteral Feeding Device Market, U.S., 2016 (1 of 5) 82
Figure 3 21: Core Companies, Enteral Feeding Device Market, U.S., 2016 (2 of 5) 83
Figure 3 22: Core Companies, Enteral Feeding Device Market, U.S., 2016 (3 of 5) 84
Figure 3 23: Core Companies, Enteral Feeding Device Market, U.S., 2016 (4 of 5) 85
Figure 3 24: Core Companies, Enteral Feeding Device Market, U.S., 2016 (5 of 5) 86
Figure 3 25: Core Companies, Anti-Reflux Device Market, U.S., 2016 89
Figure 3 26: Core Companies, Barret’s Esophagus Ablation Device Market, U.S., 2016 91
Figure 3 27: Class 2 Device Recall Olympus Duodenoscope 92
Figure 3 28: Class 2 Device Recall Olympus Gastroscope 92
Figure 3 29: Class 2 Device Recall Fujifilm Duodenoscope 93
Figure 3 30: Class 2 Device Recall Fujifilm Image processor for Endoscopy 93
Figure 3 31: Class 2 Device Recall Fujifilm Duodenoscopes 93
Figure 3 32: Class 2 Device Recall Fujifilm Ultrasound Endoscope 93
Figure 3 33: Class 2 Device Recall EndoChoice Colonoscope 94
Figure 3 34: Class 2 Device Recall Pentax Ultrasound Video Gastroscopes 94
Figure 3 35: Class 2 Device Recall Pentax 95
Figure 3 36: Class2 Device Recall Integrated Medical Systems Inc., Olympus refurbishment flexible endoscopes 96
Figure 3 37: Class 2 Device Recall Xlumenia NAVIX Access Device 97
Figure 3 38: Class 2 Device Recall Boston Scientific Rigiflex Single-Use Achalasia Balloon Dilator 97
Figure 3 39: Class 2 Device Recall Idev Technologies, Inc. (Abbot Vascular) 97
Figure 3 40: Class 2 Device Recall Cordis Corporation 97
Figure 3 41: Class 2 Device Recall C.R. Bard Core Biopsy Instrument 98
Figure 3 42: Class 2 Device Recall Boston Scientific TWISTER PLUS Rotatable Retrieval Device 99
Figure 3 43: Class 2 Device Recall US Endoscopy Group Talon Grasping Device 99
Figure 3 44: Class 2 Device Recall US Endoscopy Group Raptor grasping device 99
Figure 3 45: Class 2 Device Boston Scientific Extractor Pro RX Retrieval Balloon Catheter 100
Figure 3 46: Class 2 Device Boston Scientific Extractor Pro XL Retrieval Balloon Catheter 100
Figure 3 47: Class 2 Device Cordis Corporation FLEXSTENT Biliary Self Expanding Stent System 100
Figure 3 48: Class 2 Device Cordis Corporation PRECIS (R) Rx Nitinol Stent System 100
Figure 3 49: Class 2 Device Olympus Electrosurgical Unit. 101
Figure 3 50: Class 2 Device Recall Medtronic / Covidien Kangaroo Connect Enteral Feeding Pump 102
Figure 3 51: Class 2 Device Recall Medtronic / Covidien Kangaroo Polyurethane Feeding Tube 102
Figure 3 52: Class 2 Device Recall Applied Medical Technology Low-Profile Transgastric-Jejunal Feeding Device 102
Figure 3 53: Class 2 Device Recall Kimberly Clark / Halyard MIC Gastroentric feeding tube 102
Figure 3 54: Class 2 Device Recall Xeridiem Mediem Medical Devices EndoVive 3s Low Profile Balloon Kits 103
Figure 3 55: Class 2 Device Recall Moog Medical Device Group EnteraLite Infinity Enteral Pump Delivery Set with ENFit Connector System 104
Figure 3 56: Class 2 Device Recall Moog Medical Device Group Infinity Enteral Feeding infusion pump 104
Figure 3 57: Class 2 Device Recall Moog Medical Device Group Infinity Pump 104
Figure 3 58: Class 2 Device Recall Nestle HealthCare Nutrition Compat Nasogastric Feeding Tube 104
Figure 3 59: Class 2 Device Recall Corpak Med System CORFLO Ultra Jejunal Tube with CORLOCKTwoomey Y-adaptor 105
Figure 3 60: Class 2 Device Recall Given Imaging Bravo pH capsule delivery device 106
Figure 3 61: Class 2 Device Recall Given Imaging Bravo pH Monitoring capsule 106
Figure 3 62: Class 2 Device Recall EndoGastric Solution EsophyX2 Plus Device and Accessories 106
Figure 3 63: Class 2 Device Recall Covidien HALO Flex Energy Generators 107
Figure 3 64: GI Endoscopes –Exploratory Study of Upper and Lower Endoscopic Fuse System 109
Figure 3 65: GI Endoscopes – Infrared Endoscope for diagnosis gastric cancer 109
Figure 3 66: GI Endoscopes – Assessing Endoscopic Mucosal Resection Site Using Different Endoscopic Imaging Methods 110
Figure 3 67: GI Endoscopes – A 4-arm Clinical Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy 111
Figure 3 68: GI Endoscopes – Cap Assisted Balloon Enteroscopy Versus Conventional Balloon Enteroscopy 112
Figure 3 69: GI Endoscopes – Transnasal Endoscopy 112
Figure 3 70: GI Endoscopes – Post-marketing Study of SC20 Colonoscope (SC20 Scope) 112
Figure 3 71: GI Endoscopes – ENdocuff Optimisation of Mucosal Abnormalities 113
Figure 3 72: GI Endoscopes – Cap-assisted Endoscopy 113
Figure 3 73: GI Endoscopes – Visualization Balloon for Colonoscopy 113
Figure 3 74: GI Endoscopes – Third Eye Panoramic Device 114
Figure 3 75: GI Endoscopes – Disposable Sheathed Gastroscopic System 114
Figure 3 76: GI Endoscopes – Motus GI CleanUp System for Colonoscopy 114
Figure 3 77: GI Endoscopes – The Peerscope System™ for Polyp Detection 115
Figure 3 78: GI Endoscopes – Double-balloon Colonoscopy 115
Figure 3 79: GI Endoscopes – Magnetic Endoscope Imaging (MEI) in Single-balloon Enteroscopy 115
Figure 3 80: GI Endoscopes – ColoAssist vs. Magnetic Endoscope Imaging 116
Figure 3 81: GI Endoscopes – Visualization Technique in Colonoscopy 116
Figure 3 82: GI Endoscopes – Imaging Techniques 116
Figure 3 83: Capsule Endoscopy – Gastric Capsule Examination for Iron Deficiency Anaemia 117
Figure 3 84: Capsule Endoscopy – Tethered Capsule Endoscope for Barret's Esophagus 117
Figure 3 85: Capsule Endoscopy – Remote-controlled Capsule Endoscopy 118
Figure 3 86: Capsule Endoscopy – PillCam Colon Capsule Endoscopy and CT-colonography 118
Figure 3 87: Capsule Endoscopy – PillCam Colon Capsule 2® (PCC2 119
Figure 3 88: Capsule Endoscopy – Magnetically Guided Capsule Endoscopy vs. High Definition Gastroscopy 119
Figure 3 89: Capsule Endoscopy – Colon Capsule Endoscopy (CCE) vs. CT Colonography (CTC) 120
Figure 3 90: Capsule Endoscopy – Colon Capsule and Virtual Colonoscopy 120
Figure 3 91: Virtual Colonoscopy – Colonoscopy Methods for Screening Colorectal Cancer 121
Figure 3 92: Virtual Colonoscopy – CT-Colonography with Standard CT Scan and Optical Colonoscopy 121
Figure 3 93: Virtual Colonoscopy – Detection Rate of a Colorectal Cancer: CT Colonography vs. Flexible Sigmoidoscopy 122
Figure 3 94: Stenting and Dilation – Evaluation of the New Procedure of Gastro Duodenal Anastomos using NOTES 123
Figure 3 95: Stenting and Dilation – Newly Designed Covered Stent and Uncovered Stent for Malignant Colorectal Obstruction 123
Figure 3 96: Stenting and Dilation – Covered Versus Uncovered Self-expandable Metallic Stents 124
Figure 3 97: Stenting and Dilation – WallFlex™ Esophageal Fully Covered Metal Stents in Caustic Strictures Study 124
Figure 3 98: Stenting and Dilation – Comparison of FCSEMS and Plastic Stents (WON-MVP) 125
Figure 3 99: Stenting and Dilation – Removal of the Evolution® Esophageal Stent - Fully Covered 125
Figure 3 100: Stenting and Dilation – WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture 126
Figure 3 101: Stenting and Dilation – EndoMAXX EVT Compared to EndoMAXX 126
Figure 3 102: Stenting and Dilation – Covered Metallic Stent and Benign Colonic Strictures 127
Figure 3 103: ERCP – ERCP Guided Cholangiopancreatoscopy with the SpyGlass DS (SPYDS) 128
Figure 3 104: ERCP – WallFlex Biliary Fully Covered (FC) Chronic Pancreatitis Study 128
Figure 3 105: ERCP – Endoscopic Papillary Large Balloon Dilation 129
Figure 3 106: ERCP – Evolution® Biliary Stent System-Fully Covered 129
Figure 3 107: ERCP – Laser Versus Mechanical Lithotripsy of Bile Duct Stones 130
Figure 3 108: ERCP – Winged Perimeter Versus Traditional Plastic Biliary Stent 130
Figure 3 109: ERCP – Short Term Pancreatic Stenting Registry 131
Figure 3 110: ERCP – Endobiliary Radiofrequency Ablation with S-1 for Unresectable Cholangiocarcinoma 131
Figure 3 111: ERCP – Radiofrequency Ablation for Biliopancreatic Malignancy (IGNITE-1) 132
Figure 3 112: ERCP – Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones (SAC) 132
Figure 3 113: ERCP – Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis 133
Figure 3 114: ERCP – Covered vs Uncovered Metal Stents for Palliative Biliary Decompression 133
Figure 3 115: ERCP – Comparison of Loop-tip Cook Medical® Wire Versus Traditional Endoscopic Technique (loop) 134
Figure 3 116: ERCP – Early endoscopic ultrasound (EUS) in Acute Biliary Pancreatitis (ABP) 134
Figure 3 117: ERCP – Radiofrequency Ablation for Malignant Biliary Obstruction 135
Figure 3 118: ERCP – Prospective Evaluation of Stent Patency in Patients With Benign Biliary Obstruction of the Wing Biliary Stent (Viaduct™) 135
Figure 3 119: Biopsy Forceps, Polypectomy Snares and FNA – Comparative Effectiveness of Hot Versus Cold Snare Polypectomy of Small Colorectal Polyps (HOT/COLD) 136
Figure 3 120: Biopsy Forceps, Polypectomy Snares and FNA – Cold Snare,Hot Snare and APC Polypectomy for the Complete Removal of Small Left Sided Colon Polyps 136
Figure 3 121: Biopsy Forceps, Polypectomy Snares and FNA – Endodrill vs. EUS-guided FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract 137
Figure 3 122: Biopsy Forceps, Polypectomy Snares and FNA – Cold Snare Polypectomy vs. Hot Snare Polypectomy 137
Figure 3 123: Biopsy Forceps, Polypectomy Snares and FNA - Biopsy Forceps Versus Cold Snare for the Resection of Small Colonic Polyps 138
Figure 3 124: Biopsy Forceps, Polypectomy Snares and FNA - Comparison of Jumbo and Hot Biopsy Forceps 138
Figure 3 125: Biopsy Forceps, Polypectomy Snares and FNA - Cold Snare Polypectomy Vs. Cold Forceps Polypectomy Using Narrow-band Imaging Endoscopy for Removal of Diminutive Colorectal Polyps 139
Figure 3 126: Biopsy Forceps, Polypectomy Snares and FNA - The Effectiveness of an Exclusive Cold Snare Polypectomy Snare for the Removal of Diminutive Colorectal Polyps 139
Figure 3 127: Biopsy Forceps, Polypectomy Snares and FNA - Efficacy and Safety of a New Polypectomy Snare for Cold-polypectomy for Small Colorectal Polyps 140
Figure 3 128: Biopsy Forceps, Polypectomy Snares and FNA – linear echoendoscope (FV-EUS) Endoscope Versus Curved Linear Array 141
Figure 3 129: Prospective Comparison of Cold Polypectomy and Conventional Polypectomy for Small Colorectal Polyps in Patients Taking Antithrombotic Agents 141
Figure 3 130: Effectiveness and Safety of the Endoscopic Removal of Large and Flat Colonic Polyps With LumenR RetractorTM 142
Figure 3 131: Hemostasis device– Effectiveness Study of the BioVac Direct Suction Device in Upper GI Bleeding 143
Figure 3 132: Hemostasis device– Argon Plasma Coagulation for Bleeding Peptic Ulcers 143
Figure 3 133: Enteral Feeding Devices – A Trial of Bedside Placement of Nasal Jejunal Tube Confirmed by Ultrasound Compared to Placement by Endoscope in Patients With SAP 144
Figure 3 134: Enteral Feeding Devices – PEG by Introducer Method Via EG Scan 144
Figure 3 135: Anti-Reflux Devices – Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease 145
Figure 3 136: Anti-Reflux Devices – Medigus Ultrasonic Surgical Endostapler (MUSE) Registry 145
Figure 3 137: Anti-Reflux Devices – Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study 146
Figure 3 138: Anti-Reflux Devices – Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial (GMT) 146
Figure 3 139: Barrett’s Esophagus Ablation devices– Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer 147
Figure 3 140: Barrett’s Esophagus Ablation devices– Multi-center Clinical Study to Evaluate the Coldplay Focal Ablation System (ColdPlay3) 147
Figure 3 141: Barrett’s Esophagus Ablation devices– Radiofrequency Ablation for the Treatment of Gastric Dysplasia 148
Figure 3 142: Barrett’s Esophagus Ablation devices– A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy (DOSE) 148
Figure 3 143: Barrett’s Esophagus Ablation devices– Spray Cryotherapy for Esophageal Cancer (ICE-CANCER) 149
Boston Scientific
Olympus
Medtronic
Cook Medical
Halyard
Medline
Pentax
ConMed
Fujinon
Moog
C. R. Bard
Endogastric
GE Healthcare
Others include: Alcor Scientific, Applied Medical Technologies, BARD, C2 Therapeutics, Capso Vision, ConMed, CSA Medical, Endochoice, ERBE, Genii, GI Supply, Hobbs Medical, Intromedic, Mederi, Medigus, Medivators, Medline, Merit Endotek, Micro-tech Endoscopy, Mobile Instruments, Moog, Northfield Instruments, Philips, Prezio, MedService International, Rendoscopy, Siemens, Steris, Taewoon Medical, Telemed Systems, TeraREcon, Torax, US Endoscopy, Viatronix, Vital Images, and others.
